Brief: S Biomedics Cell Therapy For Parkinson's Disease Shows Positive Data From Phase 1/2a Clinical Trial
21/07/2025 10:36
July 21 (Reuters) - S Biomedics Co Ltd 304360.KQ: S BIOMEDICS CO LTD: CELL THERAPY FOR PARKINSON'S DISEASE SHOWS POSITIVE DATA FROM ITS PHASE 1/2A CLINICAL TRIAL Source text: ID:nGNXbRwWsM Further company coverage: 304360.KQ ((Reuters.Briefs@thomsonreuters.com;))